DN-PROteom + DiaPat Heart failure and coronary heart disease Test
Description: DN-PROteom + DiaPat Heart failure and coronary heart disease Test, biomolecular detection of diabetic nephropathy and cardiovascular disease.
In view of the new legal situation for in-vitro diagnostics of the new EU directive, all DiaPat tests, such as urine samples, are only to be carried out under the instruction of a doctor and only through him the diagnostic results are giving to the patient. *
* You can still order the self-payer test from us, receive the test set after payment and take it to your doctor. The instructions for your doctor are attached.
Please also read our Product data sheet and the recommendations/instructions at the end of this page.
The DiaPat® DN-PROteom +DiaPat Heart failure and coronary heart disease Test consists of the following two individual tests
The DiaPat® DN-PROteom test, in the scientific community also known as "CKD273", is the extremely reliable, non-invasive method for the diagnosis of diabetic nephropathy (DN) in patients with type I or type II diabetes.
The test recognizes renal impairment years in advance to other clinical and laboratory tests and years before clinical signs and symptoms of irreversible kidney damage will occur. DN as a severe complication of diabetes is gaining more and more momentum in its initial phase of disease progression being at this time only detectable on the molecular level. Preventive measures taken after a positive DiaPat® DN-PROteom Test in this early phase slow down this unfavorable outcome and therefore provide a foundation for an otherwise unattainable success in therapy.
DiaPat Heart failure and coronary heart disease Test
The DiaPat Heart failure and coronary heart disease Test a test in urine that predicts the risk of heart failure caused by calcified arteries (arteriosclerosis). Before the first clinical symptoms occur, the DiaPat Heart failure and coronary heart disease Test very reliably detects even the smallest, not yet visible plaque deposits by analyzing 238 arteriosclerosis-specific proteins. The test is currently the only diagnostic tool available to detect plaques at this early stage. Based on these test characteristics, the DiaPat Heart failure and coronary heart disease Test ensures timely diagnosis and significantly improves the success of therapy so that heart attack and ischemic stroke can be prevented. The DiaPat Heart failure and coronary heart disease Test is a clinically validated valuable method for early detection and subsequent therapy guidance.
Instructions for use
For the DiaPat® test, the midstream of second morning urine is collected in a urine cup. The urine is then transferred to the enclosed urine monovette (sample syringe) *. The urine monovette is placed in protective packaging* for transport. Transport to the laboratory will be carried out per overnight express (see also instructions for use).
*These materials will be provided as part of the DiaPat® sample collection kit
The DiaPat® Kombi-test includes the following services:
The DiaPat® package includes the sample set for collecting the urine sample and all the necessary documents. The shipment will be operated by a courier by home pickup or via the doctor's office.
The analysis will be conducted in our central laboratory using the CE-MS technology.
Medical history questionnaire form
A detailed medical history questionnaire is part of the sampling kit. Please fill it out carefully and completely. The information is the basis for a reliable evaluation of the DiaPat® test result.
Send the result letter to your family doctor
The result of the protein analysis, which we send to your doctor, is explained in detail and gives recommendations for further diagnostic steps.